StreetAlpha.app
Home › Stocks › LLY

ELI LILLY & Co (LLY)

Healthcare
$1415.43
▼ −1.13%
LAST CLOSE · NOV 17

Eli Lilly is a pharmaceutical company that develops and sells medicines for diabetes, obesity, cancer, and other conditions. It last closed at $1415.43 on Nov 17, down 1.13% on the day. LLY reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 15 analysts is $1539.20 (+8.7% from the last close), with a high of $1700.00 and a low of $1250.00. Analyst consensus is Strong Buy, based on the latest ratings from 15 firms (15 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 44 whale options trades in LLY, 50% of them bullish and 50% bearish. In the past 30 days there were 146 dark pool prints totaling $185.3M, the largest $38.2M.

AI Auto Pilots
Is LLY in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$86.5B
+45.5% vs a year ago
Net income
$27.6B
+49.8% vs a year ago
EPS (diluted)
$30.81
+50.7% vs a year ago
Gross margin
83.6%
$72.3B gross profit
Valuation
Market cap
$1.33T
940.7M shares
P/E
45.9
Price over 12 month EPS
Price to sales
15.4
Market cap over revenue
Dividend yield
0.47%
$6.69 a share over 12 months
Balance sheet
Cash & equivalents
$4.9B
At Sep 30
Debt
$49.5B
At Sep 30
Shareholder equity
$40.3B
Buybacks
$5.8B
Last 12 months
CEODavid A. Ricks
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $28.3B$28.3BFY2021FY2022: $28.5B$28.5BFY2022FY2023: $34.1B$34.1BFY2023FY2024: $45.0B$45.0BFY2024FY2025: $65.2B$65.2BFY2025

From LLY's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Feb 3
2027 · Time not announced
Consensus EPS forecast
$11.22
$24.58B revenue est.
Year-ago EPS
$7.54
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 15 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
15firms
15 Buy0 Hold0 Sell
Each firm's latest rating on LLY in the past 90 days
Average 12-month target
$1539.20
▲ 8.7% upside

Based on 15 analysts who set a price target on LLY in the past 90 days. The average target is $1539.20, with a high of $1700.00 and a low of $1250.00, compared with the last close of $1415.43.

$1013$1259$1505$1751PAST 112 TRADING DAYS12-MONTH TARGETSHIGH $1700AVG $1539.20LOW $1250May 22LAST CLOSE+12 MO$1013$1259$1505$1751PAST 112 DAYSTARGETSHIGH $1700AVG $1539.20LOW $1250May 22LAST CLOSE+12 MO
Highest target$1700.00
Average target$1539.20
Lowest target$1250.00
Latest rating changes
BarclaysMaintained
Nov 16Buy$1550
JefferiesTarget raised
Nov 9Buy$1350 → $1700
Cantor FitzgeraldTarget raised
Nov 2Buy$1440 → $1600
UBSTarget raised
Oct 31Buy$1425 → $1625
JP MorganTarget raised
Oct 30Buy$1500 → $1650
DateFirmActionRatingPrice target
Nov 16BarclaysMaintainedBuy$1550
Nov 9JefferiesTarget raisedBuy$1350 → $1700
Nov 2Cantor FitzgeraldTarget raisedBuy$1440 → $1600
Oct 31UBSTarget raisedBuy$1425 → $1625
Oct 30JP MorganTarget raisedBuy$1500 → $1650
Loading…

Technical Analysis

LLY · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought

The stock is 3% above its 20 day and 12% above its 50 day average. It is 21% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 63), near overbought. The nearest support is the Pivot S1 at $1400.22, and the nearest resistance the Pivot at $1416.25.

Short trendBullish
Long trendBullish
MomentumImproving
StretchNear overbought
VolatilityHigh, 3.1%/day
Key levels
$1475.2552 week high+4.2%
$1449.68Swing high (Oct 30)+2.4%
$1431.46Pivot R1+1.1%
$1416.25Pivot+0.1%
$1415.43Last close
$1400.22Pivot S1−1.1%
$1372.4020 day average−3.0%
$1333.22Swing low (Nov 6)−5.8%
$1252.5650 day average−11.5%
$1221.19100 day average−13.7%
$1113.15200 day average−21.4%
$850.5152 week low−39.9%
Indicators
RSI (14)62.99Strong, overbought above 70Neutral
MACD52.80Below its signal lineBearish
Stochastic76.8Middle of its rangeNeutral
ADX (14)38.0Trending up
Williams %R-41.2Oversold below −80, overbought above −20Neutral
CCI (20)50.2Oversold below −100, overbought above 100Neutral
Rate of change+0.4%Change over 10 sessionsBullish
ATR (14)$43.60Typical daily range, 3.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for LLY

What happened before

See how LLY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow is mixed22 bullish and 22 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow LLY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How LLY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
44
Bullish
22
50%
Bearish
22
50%
Date span
Aug 20 – Nov 16
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
146
Notional
$185.3M
Largest print
$38.2M
Loading…

LLY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲2,321 buying vs 1,713 selling
  • ▼Held by funds -1.7 pts
  • ●Funds holding -46
  • ▲Superinvestors: 4 added, 3 cut
  • ▲Put/call 1.91 to 1.47
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding4,6024,648−1.0%
In funds' top 10448479−6.5%
Held by funds82.6%84.3%−1.7 pts
New / increased162 / 2,159351 / 2,184−8.4%
Reduced / sold out1,569 / 1441,461 / 108+9.2%
Put/call ratio1.471.91−23.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LLY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

LLY Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$5.8B
0.4% yield
Left in program
$6.6B
0.5% of value
Shares outstanding, 12 months
−0.5%
Fewer shares
Last quarter
$373.8M
Sep 2026
Avg price paid, last quarter
$1168.00
320K shares bought
S&P 500 rank by spending
#44 of 358
 
Spent each quarter, last 3 yearsTop bar $2.3B
Dec 2023: $196K, average price $151.51Mar 2024: $0Jun 2024: $0Sep 2024: $521.5M, average price $896.13Dec 2024: $2.2B, average price $534.72Mar 2025: $1.2B, average price $883.24Jun 2025: $692.3M, average price $761.63Sep 2025: $707.6M, average price $699.86Dec 2025: $1.5B, average price $1001.57Mar 2026: $2.3B, average price $987.16Jun 2026: $1.6B, average price $975.65Sep 2026: $373.8M, average price $1168.00
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LLY is in one of them and how their past LLY trades turned out.

LLY in the AI portfolios
Loading…

LLY News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LLY in an article yet. Here's the latest on the wider market.

LLY Congress Trades

All congress trades →
Trades, 12 months
36
Buys
16
44%
Sells
20
56%
People
14
Last filed Nov 13
Who traded LLY · since 2017
Latest 5 filings of 208
$1K – $15KTraded Nov 3, 2026Filed Nov 13, 2026
$1K – $15KTraded Nov 3, 2026Filed Nov 13, 2026
$1K – $15KTraded Oct 20, 2026Filed Nov 10, 2026
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
$15K – $50KTraded Jul 23, 2026Filed Sep 22, 2026
PersonTypeAmountTradedFiledDelay
David TaylorR · OHSell$1K – $15KNov 3, 2026Nov 13, 202610 d
David TaylorR · OHSell$1K – $15KNov 3, 2026Nov 13, 202610 d
Gilbert CisnerosD · CABuy$1K – $15KOct 20, 2026Nov 10, 202621 d
Ro KhannaD · CABuy$1K – $15KSep 4, 2026Oct 7, 202633 d
Donald J TrumpExecutive branchBuy$15K – $50KJul 23, 2026Sep 22, 202661 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About ELI LILLY &

Eli Lilly is a pharmaceutical company based in Indianapolis, Indiana. It discovers, develops, manufactures, and sells human medicines, with major products for diabetes and obesity, as well as treatments for cancer, immune conditions, migraine, and Alzheimer's disease. Its customers include wholesalers, pharmacies, hospitals, insurers, and healthcare providers, and it also sells directly to patients through its LillyDirect platform. Its products are sold in many countries around the world.

Headquarters
Indianapolis, IN
Founded
1875